Articles by Mackenzie Tatananni
Sionna Therapeuticsis shelving its highly anticipated cystic fibrosis drug candidate, SION-719, after it failed to meet the key endpoint in a proof-of-concept trial.
Copyright Β©2026Dow Jones & C...
Applestock was downgraded by a major Wall Street firm on Monday, as an analyst predicted that a radical iPhone redesign has been scrapped.
Copyright Β©2026Dow Jones & Company, Inc. All Rights Res...
AbCellera Biologics shares surged on Monday after the biotechnology companys menopause drug candidate delivered compelling results in an early-stage trial.
Copyright Β©2026Dow Jones & Company, In...
Replimune Groupreceived Food and Drug Administration clearance for its skin cancer drug, concluding a saga that saw regulators twice deny its application. The stock was falling anyway.
Copyright Β©20...
Rigetti Computingnarrowly beat revenue forecasts as sales of its quantum computers picked up speed in the latest quarter, though widening losses and ongoing commercialization costs prevented a rally οΏ½...
Wall Street was met with a tale of two quantum computing companies on Thursday, asIonQstock extended gains following a stronger-than-expected quarterly earnings report while shares ofD-Wave QuantumheοΏ½...
IonQkicked off the quantum earnings season on Wednesday, posting what its chief executive called the strongest quarter in the companys history.
Copyright Β©2026Dow Jones & Company, Inc. All Right...
Novo NordisksU.S.-listed shares were paring earlier losses after the Danish drugmaker released its second-quarter earnings a day early.
Copyright Β©2026Dow Jones & Company, Inc. All Rights Reserv...
Novo NordisksU.S.-listed shares slumped after the Danish drugmaker released its second-quarter earnings a day early.
Copyright Β©2026Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d...
Pfizerlifted the bottom end of its full-year revenue guidance on Tuesday, citing growth in its non-Covid pharmaceutical portfolio. Its smaller Covid vaccine partner offered a less optimistic outlook.οΏ½...
